Engineering lipid-based nanocarriers for PROTAC delivery: evaluating the influence of manufacturing and morphology on pharmacokinetic exposure
Authors:
- Ponien KouPKPonien Kou
- Matthew O’BRien LaramyMLMatthew O’BRien Laramy
- Andrew LathamALAndrew Latham
- Cheng ChiangCCCheng Chiang
- Donglu ZhangDZDonglu Zhang
- Jodie PangJPJodie Pang
- Yusi CuiYCYusi Cui
- Nanzhi ZangNZNanzhi Zang
- Shijia TangSTShijia Tang
- Karthik NagapudiKNKarthik Nagapudi
- Vijay SethuramanVSVijay Sethuraman
- Elizabeth S. LevyELElizabeth S. Levy
Open Access
- 3 October 2026
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 705
Abstract
No abstract availableFunding Information
- Genentech
This publication has 38 references indexed in Scilit:
- Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein DegradationMacromolecular Rapid Communications, 2025
- PROteolysis TArgeting Chimeras (PROTACs) — Past, present and futureDrug Discovery Today: Technologies, 2019
- Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugsEBioMedicine, 2018
- Lessons in PROTAC Design from Selective Degradation with a Promiscuous WarheadCell Chemical Biology, 2018
- Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation2016
- Selectively targeting estrogen receptors for cancer treatmentAdvanced Drug Delivery Reviews, 2010
- Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- The Amber biomolecular simulation programsJournal of Computational Chemistry, 2005
- Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validationJournal of Computational Chemistry, 2002
- Multidimensional free‐energy calculations using the weighted histogram analysis methodJournal of Computational Chemistry, 1995